Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moleculin Biotech CS
(NQ:
MBRX
)
2.430
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Sep 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
15,437
Open
2.530
Bid (Size)
2.350 (18)
Ask (Size)
2.750 (2)
Prev. Close
2.430
Today's Range
2.420 - 2.630
52wk Range
2.115 - 15.75
Shares Outstanding
2,227,516
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q2 2024
August 14, 2024
MBRX stock results show that Moleculin Biotech beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 14, 2024
Via
Benzinga
Performance
YTD
-82.47%
-82.47%
1 Month
-2.80%
-2.80%
3 Month
-41.30%
-41.30%
6 Month
-67.24%
-67.24%
1 Year
-58.67%
-58.67%
More News
Read More
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q1 2024
May 10, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 26, 2024
Via
Benzinga
Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
April 25, 2024
Via
ACCESSWIRE
MBRX Stock Earnings: Moleculin Biotech Reported Results for Q4 2023
March 22, 2024
Via
InvestorPlace
A Preview Of Moleculin Biotech's Earnings
March 21, 2024
Via
Benzinga
Moleculin Biotech's Earnings: A Preview
November 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 08, 2024
Via
Benzinga
Earnings Scheduled For March 22, 2024
March 22, 2024
Via
Benzinga
Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday
March 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 24, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 09, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 30, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 28, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 22, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 21, 2023
Via
Benzinga
Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%
November 13, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 24, 2023
Via
InvestorPlace
Earnings Scheduled For November 13, 2023
November 13, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
